NexgenRx Inc.  

(Public, CVE:NXG)   Watch this stock  
Find more results for David C. Loucks
0.000 (0.00%)
Aug 24 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range     -
52 week 0.08 - 0.25
Open     -
Vol / Avg. 0.00/24,552.00
Mkt cap 8.82M
P/E     -
Div/yield     -
EPS 0.00
Shares 58.77M
Beta 0.02
Inst. own     -
Nov 18, 2015
Q3 2015 NexgenRx Inc Earnings Release (Estimated) Add to calendar
Aug 19, 2015
Q2 2015 NexgenRx Inc Earnings Release

Key stats and ratios

Q2 (Jun '15) 2014
Net profit margin 9.33% -11.33%
Operating margin 9.33% -11.33%
EBITD margin - -8.54%
Return on average assets 54.33% -46.52%
Return on average equity - -
Employees 20 -
CDP Score - -


185 The West Mall, Suite 600
+1-416-6953393 (Phone)
+1-416-6951635 (Fax)

Website links


NexgenRx Inc. is a Canada-based company, which administers, adjudicates and pays drug, dental and other extended health-care claims for the beneficiaries of health benefit plans. The Company earns revenue on the sale of its administration and health benefit claims adjudication services to various organizations who manage health benefit plans on behalf of a number of plan sponsors and to a lesser extent directly to Canadian plan sponsors who wish to provide an Administrative Services Only (ASO) health benefit plan to their plan members. Health benefit claims include drug, dental, extended health and health care spending account claims. This service is sold on a fee-per-transaction basis, in addition to a per member administration fee. It provides claims adjudication services covering three benefit classes; drug, dental and extended health care, plus a healthcare spending account.

Officers and directors

Thomas F. Corcoran Chairman of the Board
Ronald C. Loucks President, Chief Executive Officer, Director
Taba Merrikh Acting Chief Financial Officer
Patrick G. Crowley Director
Barry J. Reiter Director
Age: 66
Ralph Soberano Director
David A. Rosenkrantz Independent Director